Peposertib, a DNAPK inhibitor, enhances the antitumor efficacy of anthracyclines in triple-negative breast cancer models in vitro and in vivo

被引：1
|
作者：
Revia, Steffie
Sirrenberg, Christian
Schach, Antonia
Zimmermann, Astrid
Zenke, Frank T.
Albers, Joachim
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6215
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Peposertib, a DNA-PK Inhibitor, Enhances the Anti-Tumor Efficacy of Topoisomerase II Inhibitors in Triple-Negative Breast Cancer Models
    Revia, Steffie
    Neumann, Felix
    Jabs, Julia
    Orio, Florian
    Sirrenberg, Christian
    Zimmermann, Astrid
    Amendt, Christiane
    Albers, Joachim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [2] In Vitro and In Vivo Antitumor Activity of the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Triple-Negative Breast Cancer Models
    Diamond, J. R.
    Eckhardt, S. G.
    Tan, A. C.
    Selby, H. M.
    Newton, T. P.
    Pitts, T. M.
    Bray, M. R.
    Fletcher, G. C.
    Tentler, J. J.
    CANCER RESEARCH, 2011, 71
  • [3] Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer
    Craig Davison
    Roisin Morelli
    Catherine Knowlson
    Melanie McKechnie
    Robbie Carson
    Xanthi Stachtea
    Kylie A. McLaughlin
    Vivien E. Prise
    Kienan Savage
    Richard H. Wilson
    Karl A. Mulligan
    Peter M. Wilson
    Robert D. Ladner
    Melissa J. LaBonte
    npj Breast Cancer, 7
  • [4] Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer
    Davison, Craig
    Morelli, Roisin
    Knowlson, Catherine
    McKechnie, Melanie
    Carson, Robbie
    Stachtea, Xanthi
    McLaughlin, Kylie A.
    Prise, Vivien E.
    Savage, Kienan
    Wilson, Richard H.
    Mulligan, Karl A.
    Wilson, Peter M.
    Ladner, Robert D.
    LaBonte, Melissa J.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [5] Lymphatics in triple-negative breast cancer: Contribution to chemotherapeutic efficacy in vitro and in vivo
    Harris, Alexandra H.
    Munson, Jennifer M.
    CANCER RESEARCH, 2016, 76
  • [6] Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro
    Yin, Lin-Lin
    Wen, Xin-Mian
    Lai, Qing-Hua
    Li, Jing
    Wang, Xiu-Wen
    ONCOLOGY LETTERS, 2018, 15 (05) : 6469 - 6474
  • [7] Triple-negative Breast Cancer: Identification of circRNAs With Efficacy in Preclinical In Vivo Models
    Weidle, Ulrich H.
    Birzele, Fabian
    CANCER GENOMICS & PROTEOMICS, 2023, 20 (02) : 117 - 131
  • [8] Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancer
    Han, Beom Seok
    Jung, Kyung Hee
    Lee, Ji Eun
    Yoon, Young-Chan
    Ko, Soyeon
    Park, Min Seok
    Lee, Yun Ji
    Kim, Sang Eun
    Cho, Ye Jin
    Lee, Pureunchowon
    Lim, Joo Han
    Jang, Eunsoo
    Kim, Hyunzu
    Hong, Soon-Sun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 3083 - 3098
  • [9] Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro
    Garza-Morales, Rodolfo
    Gonzalez-Ramos, Roxana
    Chiba, Akiko
    Montes de Oca-Luna, Roberto
    McNally, Lacey R.
    McMasters, Kelly M.
    Gomez-Gutierrez, Jorge G.
    CANCERS, 2018, 10 (05)
  • [10] IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo
    Lalita Guntuku
    Jagadeesh Kumar Gangasani
    Dinesh Thummuri
    Roshan M. Borkar
    Bramanandam Manavathi
    Srinivas Ragampeta
    Jayathirtha Rao Vaidya
    Ramakrishna Sistla
    Naidu G. M. Vegi
    Oncogene, 2019, 38 : 581 - 595
12345